sexual dysfunction: ['Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty.']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
832 |
4. Check minimum number of eventsNone |
832 |
5. Include endpointsNone |
832 |
6. Filter based on genotype QC (FinnGen only) |
734 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHAVE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F50-F59
- Name in latin
- Perturbationes sexuales non organicae
Similar endpoints
↥List of similar endpoints to
Sexual dysfunction
based on the number of shared cases.
Similar with more cases:
- Behavioural syndromes associated with physiological disturbances and physical factors
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3670 | 859 | 2778 |
| Only index persons | 3531 | 836 | 2695 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.02 | 0.08 |
| Only index persons | 0.09 | 0.03 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 40.63 | 32.07 | 43.31 |
| Only index persons | 40.15 | 31.85 | 42.72 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 734 | 208 | 526 |
| Unadjusted period prevalence (%) | 0.19 | 0.07 | 0.24 |
| Median age at first event (years) | 50.06 | 39.96 | 54.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 769
- Matched controls
- 7690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F52.0
ICD-10 Finland
Lack or loss of sexual desire
172.0
308.7
152
11
F52.2
ICD-10 Finland
Failure of genital response
52.2
307.7
335
112
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
154.5
143
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.9
109.1
171
268
F52.9
ICD-10 Finland
Unspecified sexual dysfunction, not caused by organic disorder or disease
248.0
87.4
88
*
F52
ICD-10 Finland
Sexual dysfunction, not caused by organic disorder or disease
24.9
86.5
62
27
N48.4
ICD-10 Finland
Impotence of organic origin
9.4
80.6
103
125
F52.6
ICD-10 Finland
Nonorganic dyspareunia
566.0
54.2
53
*
N06AX11
ATC
mirtazapine; oral
3.1
46.3
289
1263
F52.8
ICD-10 Finland
Other sexual dysfunction, not caused by organic disorder or disease
89.1
45.4
50
6
F52.4
ICD-10 Finland
Premature ejaculation
80.0
34.1
38
5
N05AH04
ATC
quetiapine; oral
3.0
33.1
181
718
N06AX12
ATC
bupropion; oral
3.9
32.7
106
303
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.3
32.1
141
492
E29.1
ICD-10 Finland
Testicular hypofunction
6.9
26.6
42
64
N05BA04
ATC
oxazepam; oral
2.5
26.4
205
963
F52.3
ICD-10 Finland
Orgasmic dysfunction
269.2
25.9
26
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
24.1
109
384
P06
ICPC
Sleep disturbance
2.9
23.5
121
458
N05CF01
ATC
zopiclone; oral
2.3
23.1
219
1117
N06AB05
ATC
paroxetine; oral
3.9
21.6
66
180
Z71.8
ICD-10 Finland
Other specified counselling
2.1
21.3
285
1662
N06AB04
ATC
citalopram; systemic
2.5
20.6
161
750
N06AX21
ATC
duloxetine; oral
2.9
20.4
106
402
N06AB06
ATC
sertraline; oral
2.8
20.0
113
449
G04BE01
ATC
alprostadil; parenteral, urethral
6.9
19.2
30
45
F52.5
ICD-10 Finland
Nonorganic vaginismus
+∞
18.8
18
*
N06AX16
ATC
venlafaxine; oral
2.6
18.5
126
548
N05CF02
ATC
zolpidem; oral
2.4
17.0
127
576
N94.1
ICD-10 Finland
Dyspareunia
15.5
16.8
27
18
P29
ICPC
Psychological sympt/compl other
2.9
16.5
83
309
SPAT1240
SPAT
Therapeutic discussion
2.7
16.3
98
400
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
16.2
218
1253
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
16.0
175
930
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.6
15.9
53
153
N06AB10
ATC
escitalopram; oral
2.1
15.9
178
955
N05AB03
ATC
perphenazine; systemic, rectal
4.1
15.8
44
112
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
15.7
270
1685
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.8
15.7
50
140
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
15.7
176
945
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.3
15.2
58
183
N05CD07
ATC
temazepam; oral
2.9
15.0
73
266
XKD00
NOMESCO Finland
Uroflowmetry
2.3
15.0
136
670
M79.6
ICD-10 Finland
Pain in limb
1.9
14.9
318
2120
N06AB03
ATC
fluoxetine; oral
2.6
14.9
93
387
F50.9
ICD-10 Finland
Eating disorder, unspecified
152.8
14.5
15
*
N06AX26
ATC
vortioxetine; oral
2.8
14.1
74
281
R53
ICD-10 Finland
Malaise and fatigue
2.0
14.0
185
1049
A02BC02
ATC
pantoprazole; systemic
1.8
13.9
493
3802
N03AX09
ATC
lamotrigine; oral
3.2
13.9
56
183
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
13.8
259
1651
N05AX12
ATC
aripiprazole; systemic
3.1
13.5
59
202
A04
ICPC
Weakness/tiredness general
2.3
13.3
115
554
N06AX22
ATC
agomelatine; oral
5.0
12.9
28
58
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
12.9
65
242
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
12.8
90
395
N03AG01
ATC
valproic acid; systemic, rectal
2.8
12.7
64
238
Z3231
NOMESCO Finland
Registered nurse
1.9
12.6
203
1226
N05AH03
ATC
olanzapine; systemic
2.7
12.5
71
281
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.5
316
2187
F34.1
ICD-10 Finland
Dysthymia
3.7
12.4
40
113
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
12.3
79
333
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
4.7
12.2
28
61
N05BA01
ATC
diazepam; systemic, rectal
2.3
12.2
95
437
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
12.1
84
366
N03AE01
ATC
clonazepam; systemic
3.1
12.0
50
167
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
11.9
200
1222
F51
ICD-10 Finland
Nonorganic sleep disorders
3.9
11.9
35
93
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
11.8
117
595
N03AX16
ATC
[U] pregabalin
2.0
11.7
156
883
R52.9
ICD-10 Finland
Pain, unspecified
2.4
11.7
88
399
A06AD11
ATC
lactulose; oral
2.3
11.6
89
406
N06BA04
ATC
methylphenidate; oral
3.2
11.4
45
145
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.8
11.2
34
92
N05AX08
ATC
risperidone; systemic
2.5
11.2
71
297
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
11.1
34
93
N06AX05
ATC
trazodone; oral
5.1
11.1
23
46
M54.5
ICD-10 Finland
Low back pain
1.7
10.8
271
1853
F32
ICD-10 Finland
Depressive episode
2.9
10.8
51
183
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
10.8
238
1572
S18
ICPC
Laceration/cut
1.7
10.6
336
2441
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
10.6
211
1351
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
10.6
75
330
R01AD09
ATC
mometasone; nasal
1.7
10.6
338
2462
R4110
NOMESCO Finland
Physiotherapy
1.8
10.5
198
1248
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
+∞
10.4
10
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
10.3
127
698
R51.80
ICD-10 Finland
Headache
2.0
10.3
123
669
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
10.1
166
1001
L12
ICPC
Hand/finger symptom/complaint
2.0
10.0
126
697
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
10.0
182
1133
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.0
126
698
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
9.9
69
301
Z2221
NOMESCO Finland
Medical doctor
1.8
9.9
197
1258
D01
ICPC
Abdominal pain/cramps general
2.2
9.9
92
455
C07AB07
ATC
bisoprolol; oral
1.6
9.8
295
2107
N06AA09
ATC
amitriptyline; systemic
2.6
9.8
56
223
P03
ICPC
Feeling depressed
2.2
9.6
86
418
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.2
9.6
82
391
N02BF01
ATC
gabapentin; oral
2.3
9.5
75
346
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
9.5
74
340
G47.3
ICD-10 Finland
Sleep apnoea
1.7
9.4
202
1316
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
5.2
9.4
19
37
R06.5
ICD-10 Finland
Mouth breathing
2.1
9.4
90
450
F50.8
ICD-10 Finland
Other eating disorders
+∞
9.4
9
*
N06AA12
ATC
doxepin; systemic
3.3
9.3
35
110
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.8
9.2
28
76
L08
ICPC
Shoulder symptom/complaint
1.8
9.2
164
1012
L17
ICPC
Foot/toe symptom/complaint
1.7
9.1
205
1351
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.1
9.1
25
63
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.7
9.1
21
46
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
9.1
237
1625
Z01.7
ICD-10 Finland
Laboratory examination
1.9
9.0
127
728
J01AA02
ATC
doxycycline; systemic
1.7
9.0
540
4524
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
9.0
133
775
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.7
8.9
20
43
UJF32
NOMESCO Finland
Coloscopy
1.8
8.9
168
1055
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.1
8.8
24
60
E0000UV, ,
ATC
1.6
8.8
288
2084
R42
ICD-10 Finland
Dizziness and giddiness
1.8
8.8
138
818
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
8.8
81
399
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
8.7
71
332
J01FF01
ATC
clindamycin; systemic
1.7
8.7
195
1282
N02BE01
ATC
paracetamol; systemic, rectal
1.8
8.7
650
5745
J02AC01
ATC
fluconazole; systemic
1.7
8.7
215
1451
P76
ICPC
Depressive disorder
2.4
8.7
62
274
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.1
8.6
35
115
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.8
8.6
19
40
M25.5
ICD-10 Finland
Pain in joint
1.6
8.6
235
1626
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
8.6
167
1055
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.8
8.5
26
71
E66.8
ICD-10 Finland
Other obesity
2.6
8.5
49
196
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.2
8.5
33
106
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
8.5
79
391
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
8.4
63
284
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
8.4
44
167
Z70.9
ICD-10 Finland
Sex counselling, unspecified
91.0
8.4
9
*
R06.0
ICD-10 Finland
Dyspnoea
1.7
8.4
173
1112
ZXD20
NOMESCO Finland
Day surgery
2.0
8.3
88
456
3027C
ICD-9 Finland
Sexual deviations and disorders, Psychosexual dysfunction[SEKSUAALINEN KIIHOTTUMISVAIKEUS]
+∞
8.3
8
*
F50.0
ICD-10 Finland
Anorexia nervosa
+∞
8.3
8
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.7
8.3
26
72
F32.1
ICD-10 Finland
Moderate depressive episode
2.4
8.3
57
248
UKC02
NOMESCO Finland
Cystoscopy
1.9
8.2
107
598
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
8.2
66
308
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.1
8.1
81
412
P01
ICPC
Feeling anxious/nervous/tense
2.0
8.1
98
534
R35
ICD-10 Finland
Polyuria
2.3
8.0
58
258
N03AX12
ATC
[U] gabapentin; oral
1.9
8.0
106
595
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.6
8.0
45
178
A02BC01
ATC
omeprazole; systemic
1.7
8.0
163
1043
R13
ICD-10 Finland
Dysphagia
2.4
8.0
53
227
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.9
98
538
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
7.9
117
682
R06AE07
ATC
cetirizine; oral
1.6
7.8
303
2267
A02BA02
ATC
ranitidine; systemic
1.9
7.8
104
585
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.2
7.8
30
96
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.9
7.7
22
57
P99
ICPC
Psychological disorders other
2.9
7.7
35
123
B07.9
ICD-10 Finland
Verruca simplex
2.9
7.7
36
129
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.7
140
867
D19
ICPC
Teeth/gum symptom/complaint
1.6
7.7
239
1700
M01AG02
ATC
tolfenamic acid; oral, rectal
1.9
7.6
93
507
N06AB08
ATC
fluvoxamine; oral
3.5
7.6
26
77
U01
ICPC
Dysuria/painful urination
2.7
7.6
40
153
WZC00, ,
SPAT
1.9
7.6
108
621
ZXA10
NOMESCO Finland
Bilateral
1.9
7.5
104
593
N06AG02
ATC
moclobemide; oral
2.9
7.4
35
126
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
7.3
50
217
L85.3
ICD-10 Finland
Xerosis cutis
9.5
7.3
14
15
F50.2
ICD-10 Finland
Bulimia nervosa
+∞
7.3
7
*
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.3
253
1841
N40
ICD-10 Finland
Hyperplasia of prostate
1.7
7.3
168
1109
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.2
345
2688
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
7.2
250
1817
A99
ICPC
Disease/condition unspecnature/site
2.1
7.1
73
374
J05AB01
ATC
aciclovir; systemic
1.7
7.1
135
844
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.4
7.1
48
207
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
7.1
90
497
N04BC05
ATC
pramipexole; oral
2.5
7.1
45
189
L86
ICPC
Back syndrome with radiating pain
2.5
7.1
45
189
N01
ICPC
Headache
1.9
7.0
84
455
R00.2
ICD-10 Finland
Palpitations
2.2
7.0
57
267
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
7.0
120
729
R03AC02
ATC
salbutamol; inhalant
1.5
7.0
378
3018
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.5
6.9
19
35
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.2
6.9
58
275
SPAT1301
SPAT
No procedures
1.6
6.9
188
1290
N02BF02
ATC
pregabalin; oral
2.4
6.8
48
211
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
6.8
126
782
N94.2
ICD-10 Finland
Vaginismus
40.4
6.8
8
*
G04CA02
ATC
tamsulosin; oral
1.6
6.7
180
1229
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.4
6.7
24
73
UJD02
NOMESCO Finland
Gastroscopy
2.7
6.7
35
133
S29
ICPC
Skin symptom/complaint other
1.7
6.7
130
818
R05
ICPC
Cough
1.6
6.7
162
1080
M79.1
ICD-10 Finland
Myalgia
1.8
6.7
109
653
N17
ICPC
Vertigo/dizziness
2.0
6.6
71
370
C07AA05
ATC
propranolol; systemic
1.7
6.6
136
868
NG4AA, ,
SPAT
7.9
6.6
14
18
D11
ICPC
Diarrhoea
1.9
6.6
88
494
G04CA01
ATC
alfuzosin; oral
1.8
6.6
114
694
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.2
6.6
52
241
H02.3
ICD-10 Finland
Blepharochalasis
2.7
6.6
34
129
X15
ICPC
Vaginal symptom/complaint other
3.1
6.6
27
90
K59.0
ICD-10 Finland
Constipation
2.6
6.5
36
141
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.7
6.5
20
55
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.5
52
242
N05BA12
ATC
alprazolam; oral
2.1
6.5
60
296
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.5
306
2365
SPAT1254
SPAT
Administration of medicine
1.9
6.4
87
491
M77.1
ICD-10 Finland
Lateral epicondylitis
2.0
6.4
68
353
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.4
116
715
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
6.3
51
238
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.6
6.3
17
31
A02BC04
ATC
rabeprazole; oral
2.1
6.3
62
313
G04BE04
ATC
yohimbine; oral
9.4
6.3
12
13
Y07
ICPC
Impotence NOS
9.4
6.3
12
13
P74
ICPC
Anxiety disorder/anxiety state
2.5
6.3
38
156
L03
ICPC
Low back symptom/complaint
1.6
6.3
192
1351
R52.2
ICD-10 Finland
Other chronic pain
2.8
6.3
30
109
F52.7
ICD-10 Finland
Excessive sexual drive
+∞
6.3
6
*
F52.11
ICD-10 Finland
Lack of sexual pleasure
+∞
6.3
6
*
J01FA06
ATC
roxithromycin; oral
1.5
6.2
252
1883
A01
ICPC
Pain general/multiple sites
2.0
6.2
64
329
H02AB04
ATC
methylprednisolone; systemic
1.8
6.2
89
512
L15
ICPC
Knee symptom/complaint
1.6
6.1
155
1042
G44.2
ICD-10 Finland
Tension-type headache
1.8
6.1
87
499
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
6.1
153
1026
Z01.2
ICD-10 Finland
Dental examination
1.5
6.1
334
2647
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.1
149
993
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
6.1
33
128
N41.1
ICD-10 Finland
Chronic prostatitis
2.6
6.1
33
128
K02.1
ICD-10 Finland
Caries of dentine
1.5
6.1
461
3886
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
6.1
256
1926
N05AD01
ATC
haloperidol; systemic
3.1
6.1
24
78
N06AA06
ATC
trimipramine; systemic
3.7
6.1
19
53
IGY02, ,
SPAT
3.5
6.0
20
58
WVA30, ,
SPAT
2.2
6.0
51
243
U05
ICPC
Urination problems other
2.5
6.0
36
147
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.3
6.0
45
204
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
178
433
5.05
70.29
2.4
1.9
40.25
37.89
nmol/l
0.60
178
418
281
1026
3.74
63.48
3.6
2.3
13.95
13.81
nmol/l
0.10
267
952
137
341
4.67
51.72
2.5
1.9
196.89
217.65
pmol/l
1.31
132
326
107
291
4.11
35.45
1.6
1.4
6.48
6.94
u/l
0.19
87
243
92
296
3.39
23.55
1.6
1.7
246.05
290.14
mu/l
0.85
87
275
588
4634
2.14
17.77
4.9
3.8
14.55
14.67
pmol/l
0.52
561
4317
498
3754
1.93
16.32
5.2
3.8
8282.90
548.48
e6/l
—
10
52
677
5719
2.54
16.24
6.1
4.5
1.84
1.86
mu/l
0.06
648
5354
414
2951
1.87
16.03
3.5
3.0
119.05
139.02
ug/l
1.28
401
2807
183
992
2.11
15.90
2.3
2.0
—
—
—
0
0
82
312
2.82
15.61
1.6
1.4
14.71
21.04
iu/l
1.26
67
264
571
4554
1.99
15.24
4.8
4.1
8.99
9.71
mm/h
0.79
550
4308
191
1075
2.03
14.89
2.4
2.0
—
—
—
0
0
582
4721
1.96
14.12
9.9
8.8
77.96
79.09
u/l
0.18
557
4534
366
2604
1.77
13.42
2.8
2.4
75.47
72.54
nmol/l
1.25
342
2409
347
2431
1.78
13.42
2.3
2.0
100.05
94.82
pmol/l
1.33
194
1372
289
1923
1.81
13.27
4.0
3.3
22.77
72.59
e6/l
0.81
204
1472
247
1642
1.74
10.95
4.0
3.2
0.21
0.46
e6/l
1.86
161
1196
79
357
2.35
10.53
3.4
3.9
4.77
4.70
pmol/l
0.21
71
327
229
1509
1.74
10.38
1.4
1.3
1.51
1.76
u/ml
0.14
67
458
20
38
5.38
10.16
1.7
1.0
4.88
6.22
umol/l
0.51
11
32
145
845
1.88
9.84
1.9
2.8
96.52
132.90
ug/g
1.08
118
704
369
2787
1.62
9.75
9.2
8.8
1.20
1.20
mmol/l
0.09
339
2454
169
1037
1.81
9.72
3.7
2.8
0.42
1.00
e6/l
2.84
77
546
261
1809
1.67
9.70
3.0
2.2
275.99
273.23
u/l
0.01
245
1735
679
6037
2.07
9.68
7.2
5.7
39.07
38.92
mmol/mol
0.14
657
5764
695
6233
2.20
9.68
17.6
13.1
87.32
88.10
ml/min/173m2
0.44
650
5709
36
113
3.29
9.56
2.3
1.5
0.18
0.44
nmol/l
2.70
23
88
342
2554
1.61
9.35
6.2
6.0
36.72
36.47
g/l
0.34
318
2424
417
3266
1.60
9.33
4.3
3.3
0.00
0.51
estimate
0.53
52
611
30
86
3.59
9.15
1.3
1.4
11.79
19.92
u/l
1.05
25
71
683
6118
2.04
9.03
5.6
4.5
5.99
5.94
mmol/l
0.27
648
5734
457
3679
1.60
8.95
12.9
10.9
3.87
4.06
e9/l
1.33
403
3208
410
3222
1.58
8.87
7.5
7.6
10.87
12.16
umol/l
2.37
387
3105
214
1441
1.67
8.73
2.2
2.2
2.55
2.72
mg/l
0.67
196
1272
711
6483
2.28
8.68
19.8
14.1
22.72
23.85
mg/l
0.41
594
5208
708
6445
2.24
8.68
22.1
16.2
139.69
139.71
mmol/l
0.07
697
6339
161
1007
1.76
8.58
3.5
2.7
14.02
14.24
umol/l
0.14
155
953
412
3260
1.57
8.51
4.4
3.3
0.00
9.81
estimate
1.33
55
670
152
941
1.77
8.38
3.5
2.7
2.32
2.33
g/l
0.08
141
881
449
3631
1.57
8.37
6.3
5.9
6.63
6.73
mmol/l
0.43
436
3432
143
870
1.79
8.37
3.6
2.7
24.26
24.38
%
0.04
137
825
407
3221
1.56
8.33
4.3
3.3
0.00
0.00
estimate
-0.00
54
669
156
975
1.75
8.32
3.7
3.0
0.77
1.40
e6/l
1.78
58
486
206
1389
1.66
8.31
1.6
1.5
2.32
2.49
g/l
0.91
133
950
110
618
1.91
8.29
2.3
2.1
379.02
366.36
nmol/l
0.30
104
581
259
1852
1.60
8.23
3.7
3.7
2.35
2.35
mmol/l
0.07
241
1723
327
2469
1.56
8.22
4.1
3.9
23.86
21.23
%
2.12
134
1021
708
6473
2.18
8.11
22.8
16.3
3.98
3.98
mmol/l
0.06
697
6352
329
2495
1.56
8.07
8.7
8.0
1.20
1.21
mmol/l
0.16
307
2339
266
1934
1.57
7.79
3.6
2.8
56.62
61.00
u/l
0.80
248
1828
106
604
1.88
7.63
6.0
6.3
—
—
—
0
0
191
1297
1.63
7.39
3.1
2.6
3.52
4.77
e6/l
0.72
174
1176
167
1098
1.67
7.33
2.1
2.0
1.48
1.48
%
0.02
154
981
39
151
2.67
7.22
1.2
1.2
—
—
—
0
0
169
1121
1.65
7.15
4.7
3.6
253.33
697.24
ng/l
1.30
122
822
169
1128
1.64
6.96
1.5
1.3
24.79
27.87
iu/ml
0.12
36
339
93
524
1.88
6.93
2.8
2.1
—
—
—
0
0
14
17
8.37
6.84
2.0
1.7
—
—
—
0
0
738
6929
2.61
6.84
14.6
11.3
29.11
30.23
u/l
0.88
727
6787
38
150
2.61
6.79
1.2
1.2
—
—
—
0
0
384
3094
1.48
6.64
5.0
4.7
2.18
2.10
ug/l
0.05
357
2835
80
436
1.93
6.58
2.6
2.0
—
—
—
0
0
212
1512
1.56
6.57
2.0
1.6
19.98
19.14
nmol/l
0.41
196
1306
569
4978
1.55
6.50
4.3
3.5
45.17
50.61
u/l
0.99
542
4794
26
86
3.09
6.40
1.6
1.4
174.52
170.29
pmol/l
0.04
26
86
47
213
2.29
6.26
1.7
1.7
—
—
—
0
0
192
1357
1.55
6.14
2.1
1.8
0.82
1.18
mg/l
0.88
144
1031
710
6604
1.98
6.08
6.4
5.2
2.71
2.78
mmol/l
1.17
684
6284
208
1502
1.53
6.02
2.9
3.4
880.62
1137.43
ng/l
0.62
182
1269
54
265
2.12
5.94
3.3
2.5
1197.78
3805.22
u/l
1.17
17
117
202
1464
1.52
5.71
4.5
3.2
1.02
1.02
kg/l
0.88
134
967
148
1003
1.59
5.65
1.5
1.3
17.37
9.04
u/ml
0.65
65
409
299
2356
1.44
5.49
4.0
3.8
31.84
34.37
u/l
0.72
288
2250
534
4690
1.45
5.29
3.3
3.1
—
—
—
0
0
337
2738
1.41
5.12
1.9
2.0
1.40
1.44
mmol/l
0.31
294
2383
699
6526
1.78
5.10
5.5
4.7
1.34
1.36
mmol/l
0.96
668
6210
201
1486
1.48
5.09
2.9
2.4
—
—
—
0
0
188
1373
1.49
5.06
1.8
1.5
—
—
—
0
0
246
1900
1.43
4.93
3.1
2.9
0.67
0.73
ug/l
0.54
151
1079
282
2234
1.41
4.90
4.3
3.4
21.49
43.24
ng/l
2.76
172
1475
65
366
1.85
4.88
5.1
4.9
111.59
89.40
ng/l
0.68
56
337
327
2662
1.40
4.83
13.8
12.8
1.19
1.21
inr
0.35
278
2215
59
323
1.90
4.83
1.1
1.0
—
—
—
0
0
18
57
3.21
4.79
1.7
1.1
—
—
—
0
0
699
6546
1.75
4.77
5.7
4.8
4.52
4.62
mmol/l
1.93
675
6262
39
186
2.16
4.65
1.3
1.4
—
—
—
0
0
56
308
1.88
4.53
1.6
1.3
—
—
—
0
0
58
324
1.85
4.47
1.8
1.6
—
—
—
0
0
99
646
1.61
4.40
1.6
1.6
—
—
—
0
0
32
147
2.23
4.20
1.2
1.3
—
—
—
0
0
68
407
1.74
4.19
1.6
1.8
—
—
—
0
0
220
1723
1.39
3.93
5.1
3.4
0.00
0.01
estimate
0.96
50
610
92
607
1.59
3.91
2.9
2.8
39.26
110.68
u/l
0.46
80
534
345
2902
1.34
3.90
3.2
2.8
—
—
estimate
—
0
0
752
7269
2.56
3.86
30.0
21.1
244.20
246.00
e9/l
0.38
742
7162
215
1686
1.38
3.80
2.5
2.9
353.74
358.53
umol/l
0.32
188
1530
75
474
1.65
3.80
2.6
2.5
69.87
73.02
ml/min/173m2
0.20
32
193
752
7276
2.52
3.72
29.9
21.1
4.66
4.67
e12/l
0.08
742
7154
665
6225
1.50
3.68
4.8
4.1
1.34
1.35
mmol/l
0.19
629
5894
135
982
1.45
3.63
3.8
3.3
2.41
2.43
mmol/l
1.16
122
885
301
2506
1.33
3.56
4.2
3.2
0.00
0.02
estimate
1.48
46
567
98
671
1.53
3.55
2.2
1.9
—
—
—
0
0
102
705
1.52
3.53
2.2
1.9
—
—
—
0
0
129
936
1.45
3.52
2.2
2.0
—
—
—
0
0
9
19
4.78
3.24
2.0
2.6
—
—
—
0
0
14
49
2.89
3.20
2.4
3.4
33.04
23.27
mu/l
0.38
14
49
141
1058
1.41
3.20
3.3
4.2
0.82
0.82
mmol/l
0.22
129
1019
265
2199
1.31
3.13
4.8
3.7
8.42
8.77
mmol/l
0.53
236
1917
105
755
1.45
3.00
2.6
3.3
7.44
9.02
umol/l
0.33
93
677
33
178
1.89
2.91
1.1
1.1
2.87
5.85
eliau/ml
—
6
23
33
181
1.86
2.78
1.2
1.1
3.40
3.86
—
9
30
35
196
1.82
2.76
1.3
1.3
—
—
—
0
0
109
803
1.42
2.74
10.7
7.7
1.06
1.02
mmol/l
0.84
101
765
107
787
1.42
2.72
1.9
1.6
1241.08
1134.59
nmol/l
0.31
86
624
28
148
1.93
2.64
1.8
1.4
340.24
2476.07
e6/l
0.85
21
114
82
580
1.46
2.57
4.5
3.6
1.59
1.70
mmol/l
0.10
76
489
64
430
1.53
2.57
1.1
1.2
27.31
165.92
u/ml
8.10
18
162
30
164
1.86
2.56
1.1
1.2
0.78
2.04
u/ml
0.86
17
92
31
172
1.84
2.54
2.5
2.4
10.69
10.26
g/l
0.17
26
161
27
144
1.91
2.49
1.7
1.3
15.26
15.38
e6/l
0.00
19
104
11
39
2.85
2.35
2.0
2.3
500.73
1295.72
u/ml
0.71
11
39
46
294
1.60
2.30
2.0
1.7
3.28
4.80
mg/l
0.74
35
211
26
143
1.85
2.21
1.7
1.6
—
—
—
0
0
10
35
2.88
2.21
1.1
1.1
—
—
—
0
0
25
136
1.87
2.20
1.8
1.3
—
—
—
0
0
37
227
1.66
2.18
1.6
2.5
198.25
498.88
ug/l
0.79
32
216
29
167
1.77
2.14
2.9
3.7
1.42
2.64
index
0.65
12
101
60
415
1.48
2.13
1.9
1.8
0.27
0.30
mg/l
0.18
24
231
19
95
2.03
2.12
1.3
1.4
—
—
—
0
0
47
312
1.54
2.03
1.5
1.5
—
—
—
0
0
40
257
1.59
1.99
1.6
2.1
1.53
1.47
g/l
0.15
32
235
22
119
1.87
1.99
1.1
1.1
18.98
18.14
au/ml
—
8
36
10
39
2.58
1.94
2.2
2.4
134.70
128.62
nmol/l
—
10
34
17
85
2.02
1.91
1.0
1.1
—
—
—
0
0
57
405
1.44
1.80
13.7
15.1
94.29
94.03
%
0.18
57
405
11
47
2.36
1.78
1.3
1.1
—
—
—
0
0
51
356
1.46
1.77
3.1
3.3
1.38
1.59
mmol/l
0.21
37
261
134
1092
1.28
1.75
1.8
1.7
71186904.71
20042168.70
pmol/l
0.32
118
958
69
511
1.38
1.74
2.6
2.4
0.10
0.33
e6/l
1.44
63
488
27
163
1.68
1.73
1.8
1.6
346.26
267.55
ug/g
0.80
17
95
18
96
1.90
1.72
1.4
1.3
—
—
—
0
0
18
96
1.90
1.72
1.4
1.3
—
—
—
0
0
63
462
1.40
1.69
1.6
1.5
—
—
—
0
0
46
321
1.46
1.62
1.6
1.4
—
—
—
0
0
5
14
3.59
1.61
1.2
1.3
—
—
—
0
0
7
26
2.71
1.58
1.7
1.7
17.11
17.57
umol/l
—
7
26
26
160
1.65
1.57
2.3
3.3
1.57
1.93
ratio
0.30
15
90
22
130
1.71
1.54
1.2
1.6
—
—
—
0
0
89
701
1.30
1.52
10.1
11.6
0.81
0.84
mmol/l
0.03
71
586
7
27
2.61
1.51
2.0
1.9
—
—
—
0
0
6
21
2.87
1.51
1.7
1.0
—
—
—
0
0
9
37
2.45
1.48
1.6
1.1
—
—
—
0
0
11
52
2.13
1.45
4.8
3.3
44.36
43.52
%
0.04
11
52
11
52
2.13
1.45
9.5
6.7
8.36
8.40
%
0.01
11
52
14
73
1.93
1.44
1.1
1.0
—
—
—
0
0
5
16
3.14
1.44
1.2
1.3
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
21.52
60.79
iu/ml
—
5
16
20
118
1.71
1.42
1.5
2.1
—
—
—
0
0
28
181
1.57
1.42
1.7
1.5
142.50
146.61
au/ml
—
10
48
10
46
2.19
1.40
2.4
2.4
—
—
—
0
0
45
323
1.42
1.39
3.0
2.6
0.54
0.63
%
1.55
45
323
16
89
1.81
1.38
1.4
1.2
—
—
—
0
0
35
240
1.48
1.37
1.7
1.5
0.22
0.07
iu/ml
—
6
35
34
233
1.48
1.34
1.8
1.7
43.23
13.88
u/ml
—
7
66
11
55
2.01
1.28
2.1
2.9
—
—
—
0
0
11
55
2.01
1.28
1.1
1.1
—
—
—
0
0
45
329
1.39
1.27
3.0
2.6
1.17
1.31
%
0.40
45
329
8
35
2.30
1.27
1.0
1.5
37.37
39.45
nmol/l
—
8
28
8
35
2.30
1.27
1.1
1.1
—
—
—
0
0
19
115
1.67
1.25
1.3
1.1
—
—
—
0
0
76
604
1.29
1.24
10.4
12.9
123.16
124.37
g/l
0.18
76
589
56
427
1.34
1.23
3.2
3.4
5.07
5.14
kpa
0.31
56
412
12
63
1.92
1.23
1.0
1.5
0.35
0.17
nmol/l
0.52
12
51
17
101
1.70
1.20
7.1
6.2
11.17
10.33
mg/l
0.30
17
91
13
73
1.79
1.11
1.3
2.1
—
—
—
0
0
64
801
0.78
1.11
1.6
1.7
3.39
3.54
mmol/l
0.43
41
579
16
96
1.68
1.11
1.1
1.1
1.79
2.53
—
5
18
14
81
1.74
1.09
1.3
2.0
—
—
—
0
0
14
81
1.74
1.09
1.1
1.3
1.21
1.47
nmol/l
0.53
14
70
15
89
1.70
1.08
1.1
1.3
—
—
—
0
0
220
1975
1.16
1.07
5.1
4.5
8.13
10.90
mg/mmol
0.51
153
1342
12
67
1.80
1.05
1.5
1.7
—
—
—
0
0
24
163
1.49
1.02
1.3
1.4
—
—
—
0
0
41
308
1.35
1.02
1.9
1.6
—
—
—
0
0
9
47
1.93
1.02
1.2
1.2
—
—
—
0
0
88
1051
0.82
1.02
1.8
2.0
3.63
3.72
ratio
0.36
64
838
23
156
1.49
0.99
1.3
1.2
—
—
—
0
0
27
190
1.44
0.98
1.7
1.2
281.21
235.89
u/ml
0.47
19
120
11
62
1.79
0.94
2.4
3.7
—
—
—
0
0
15
93
1.63
0.94
1.2
1.3
—
—
—
0
0
6
27
2.23
0.93
1.5
1.3
—
—
—
0
0
9
52
1.74
0.92
3.4
2.2
481.89
504.86
e6/l
—
9
44
26
185
1.42
0.90
1.5
1.9
—
—
—
0
0
18
119
1.52
0.88
1.0
1.1
1.33
1.49
g/l
1.07
18
105
17
111
1.54
0.88
1.4
1.2
116.75
109.95
%
0.26
12
104
10
56
1.80
0.88
1.1
1.0
—
—
—
0
0
16
103
1.57
0.88
1.2
1.1
1.22
0.32
u/ml
—
6
38
12
72
1.68
0.85
1.6
1.6
—
—
—
0
0
36
275
1.32
0.83
2.1
1.9
8.43
5.73
iu/ml
—
9
68
25
180
1.40
0.83
1.5
1.9
1.86
4.86
iu/l
—
10
68
20
138
1.46
0.82
1.1
1.1
3.21
1.43
u/ml
0.39
13
73
26
189
1.39
0.82
1.1
1.2
—
33.46
—
0
8
12
74
1.63
0.78
1.6
1.6
—
—
—
0
0
12
74
1.63
0.78
1.6
1.6
—
—
—
0
0
18
125
1.45
0.73
1.1
1.1
1.95
2.65
u/ml
0.25
11
68
9
56
1.61
0.72
1.2
2.0
—
—
—
0
0
12
76
1.59
0.72
1.1
1.0
—
—
—
0
0
46
374
1.24
0.69
9.8
16.0
16.15
16.28
%
0.11
46
360
45
365
1.25
0.69
5.0
8.3
23.54
24.59
mmol/l
0.80
45
346
7
42
1.67
0.68
1.3
1.1
2000.14
1448.17
miu/ml
—
7
42
28
362
0.76
0.68
1.4
1.6
911.67
946.54
mu/l
0.09
22
296
7
43
1.63
0.67
1.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
189
1.33
0.65
4.2
3.2
0.43
0.32
iu/ml
0.69
11
94
5
29
1.73
0.64
1.0
2.1
—
—
—
0
0
5
29
1.73
0.64
1.0
2.1
—
—
—
0
0
5
30
1.67
0.61
1.2
2.0
—
—
—
0
0
15
209
0.71
0.60
1.4
1.5
—
—
—
0
0
11
72
1.54
0.59
1.6
1.6
—
—
—
0
0
15
208
0.72
0.59
1.4
1.5
1.06
1.16
ratio
—
9
132
15
208
0.72
0.59
1.4
1.5
0.94
0.93
ratio
—
9
132
15
208
0.72
0.59
1.4
1.5
1.22
1.12
ratio
—
9
132
27
211
1.29
0.58
1.7
2.0
—
—
—
0
0
6
35
1.72
0.57
1.3
1.2
—
—
—
0
0
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
11
73
1.51
0.56
1.6
1.6
—
—
—
0
0
11
73
1.51
0.56
1.6
1.6
—
—
—
0
0
8
55
1.46
0.56
1.3
1.2
—
—
—
0
0
8
55
1.46
0.56
1.3
1.2
—
—
—
0
0
36
294
1.24
0.55
5.2
3.7
51.28
48.60
%
0.28
36
287
8
122
0.65
0.55
2.4
4.7
3611.28
368.34
u/ml
—
8
116
33
268
1.24
0.53
1.2
1.2
0.18
2.18
u/ml
—
5
13
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
23
179
1.29
0.51
2.7
1.7
—
—
—
0
0
202
1887
1.10
0.51
3.2
2.8
0.00
0.06
estimate
0.63
47
528
13
94
1.39
0.46
1.5
2.0
—
—
—
0
0
23
183
1.26
0.45
1.5
1.8
—
—
—
0
0
13
175
0.74
0.45
1.4
1.7
—
—
—
0
0
10
69
1.46
0.44
1.3
1.2
—
—
—
0
0
5
31
1.62
0.43
1.2
2.1
—
—
—
0
0
16
122
1.32
0.42
1.7
1.4
—
—
—
0
0
11
150
0.73
0.41
1.4
1.7
—
—
—
0
0
5
33
1.52
0.41
1.4
1.8
—
—
—
0
0
5
33
1.52
0.41
1.4
1.8
—
—
—
0
0
14
105
1.34
0.41
1.1
1.0
1.18
2.31
eliau/ml
—
9
46
5
34
1.47
0.40
1.0
2.0
—
—
—
0
0
5
34
1.47
0.40
1.2
2.0
—
—
—
0
0
5
34
1.47
0.40
1.0
2.0
—
—
—
0
0
5
34
1.47
0.40
1.0
2.0
—
—
—
0
0
8
60
1.34
0.40
1.3
1.2
—
—
—
0
0
27
223
1.22
0.40
2.0
1.5
1.23
1.18
g/l
0.44
27
214
28
233
1.21
0.39
2.9
3.8
24.61
24.69
mmol/l
0.07
28
220
26
215
1.22
0.38
2.1
1.5
0.24
0.24
g/l
0.01
26
207
9
122
0.73
0.35
1.4
1.6
77.22
55.23
ug/l
—
9
122
20
243
0.82
0.34
5.8
4.3
17.15
5204.33
u/ml
0.72
15
215
13
100
1.31
0.33
1.2
1.1
—
—
—
0
0
15
118
1.28
0.33
1.7
1.2
4.71
4.82
u/ml
—
7
51
6
47
1.28
0.32
3.3
1.6
—
—
—
0
0
62
561
1.11
0.32
3.4
3.2
—
—
—
0
0
7
52
1.35
0.31
1.3
1.2
—
—
—
0
0
23
193
1.20
0.31
1.6
1.8
—
—
—
0
0
7
53
1.32
0.31
1.6
1.3
—
—
—
0
0
7
53
1.32
0.31
1.7
1.3
—
—
—
0
0
7
53
1.32
0.31
3.4
2.2
—
20.27
—
0
8
44
394
1.12
0.28
9.4
5.0
1.21
1.22
mmol/l
1.14
36
351
17
140
1.22
0.27
1.1
1.7
—
—
—
0
0
9
72
1.25
0.25
1.4
1.1
—
—
—
0
0
15
123
1.22
0.25
1.4
1.1
—
—
—
0
0
11
136
0.81
0.23
3.8
10.6
105.73
105.62
mmol/l
0.02
11
121
11
136
0.81
0.23
3.8
10.6
14.27
11.47
mmol/l
0.77
11
121
42
381
1.11
0.22
1.0
1.1
1.45
1.47
g/l
0.17
42
381
26
229
1.14
0.22
2.7
3.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
43
394
1.10
0.20
1.0
1.2
0.92
0.91
g/l
0.05
43
394
14
118
1.19
0.19
1.8
1.2
2.20
3.66
u/ml
—
5
38
16
137
1.17
0.19
1.6
1.5
—
—
—
0
0
7
58
1.21
0.18
1.7
1.7
—
—
—
0
0
7
58
1.21
0.18
1.7
1.7
—
—
—
0
0
7
58
1.21
0.18
1.7
1.7
—
—
—
0
0
19
166
1.15
0.18
1.5
1.7
—
—
—
0
0
28
252
1.12
0.18
1.7
2.1
2.29
1.67
ug/l
0.13
28
229
57
533
1.07
0.17
4.2
5.2
32.31
35.12
ug/l
0.03
44
434
8
69
1.16
0.16
1.3
2.2
—
—
—
0
0
11
92
1.20
0.16
1.4
1.3
6.59
7.59
mmol/l
0.59
11
83
8
72
1.11
0.16
1.8
1.4
—
—
—
0
0
42
390
1.08
0.15
2.2
3.0
132.04
145.35
ng/l
0.14
37
350
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
30
274
1.10
0.15
1.4
1.4
188.26
210.46
miu/ml
0.11
16
130
27
247
1.10
0.13
1.5
1.5
—
—
—
0
0
18
162
1.11
0.12
2.3
2.4
18.35
114.43
ug/min
3.08
11
93
15
134
1.12
0.11
1.4
1.6
—
—
—
0
0
5
48
1.04
0.09
2.0
4.8
0.20
0.92
index
—
5
48
5
48
1.04
0.09
2.0
3.6
971.20
1371.90
mg
—
5
48
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
5
61
0.82
0.08
1.6
1.6
1.17
1.28
promille
—
5
51
5
61
0.82
0.08
2.8
2.5
1.23
1.19
mmol/l
—
5
61
5
62
0.81
0.08
2.8
2.5
105.80
104.85
mmol/l
—
5
62
28
264
1.06
0.07
4.3
3.1
25.57
25.07
mmol/l
0.42
28
254
8
90
0.89
0.06
1.5
1.8
—
—
—
0
0
14
128
1.10
0.06
1.5
1.3
—
36.00
—
0
5
15
140
1.07
0.04
1.5
1.7
—
—
—
0
0
29
281
1.03
0.02
3.9
6.9
1.82
1.63
%
0.33
29
262
70
706
0.99
0.00
5.1
4.4
30.64
30.35
%
0.08
53
501
13
133
0.98
0.00
1.4
1.2
—
—
—
0
0
11
111
0.99
0.00
1.5
1.6
—
—
—
0
0
7
78
0.90
-0.00
1.0
1.1
295.71
272.08
mg/l
—
7
71
11
110
1.00
-0.00
16.5
4.5
22.69
9.98
pmol/l
1.06
11
110
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
13.95
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.00
—
0
5
0
6
0.00
-0.00
0.0
2.3
—
22.83
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
1.38
—
0
5
0
7
0.00
-0.00
0.0
2.9
—
0.29
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.5
86.20
79.14
umol/l
—
5
49
0
8
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_SEXDYS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SEXDYS | 1.439 [1.19, 1.75] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.026 |
During the follow-up period (1.1.1998 — 31.12.2019), 176 out of 1694 males with F5_SEXDYS died.
Mortality risk
Mortality risk for people of age
years, who have F5_SEXDYS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.287% |
| 5 | No data | 1.854% |
| 10 | No data | 4.492% |
| 15 | No data | 8.385% |
| 20 | No data | 14.164% |
Relationships between endpoints
↥Index endpoint: F5_SEXDYS – Sexual dysfunction
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data